Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 496

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 496
---
                     | ​ |          — | ​ | ​ | ​ | ​      | ​ |   — | ​ | ​ | ​ | ​                        | ​ |  -786 | ​ | ​ | ​ | ​                  | ​ |       — | ​ | ​ | ​ | ​                     | ​ |       — | ​ | ​ |
| Net loss                                                                 | ​ | ​ | ​                                            | ​ |           — | ​ | ​ | ​ | ​      | ​ |     — | ​ | ​ | ​ | ​                     | ​ |          — | ​ | ​ | ​ | ​      | ​ |   — | ​ | ​ | ​ | ​                        | ​ |     — | ​ | ​ | ​ | ​                  | ​ |  -4,213 | ​ | ​ | ​ | ​                     | ​ |  -4,213 | ​ | ​ |
| Balance at September 30, 2023 (unaudited)                                | ​ | ​ | ​                                            | ​ |  95,555,554 | ​ | ​ | ​ | ​      | $ | 4,547 | ​ | ​ | ​ | ​                     | ​ | 16,666,666 | ​ | ​ | ​ | ​      | $ | 167 | ​ | ​ | ​ | ​                        | $ | 4,611 | ​ | ​ | ​ | ​                  | $ | -24,348 | ​ | ​ | ​ | ​                     | $ | -15,023 | ​ | ​ |

The accompanying notes are an integral part of these unaudited condensed financial statements. F-55

TABLE OF CONTENTS

LIMINATUS PHARMA, LLC UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS
(in thousands)

| ​                                                                        
 ​                                                                        
 Cash Flows from Operating Activities:                                    | ​ 
 ​ 
 ​ | ​ 
 ​ 
 ​ | For the nine months endedSeptember 30, 
 2024                                   
 ​                                      | ​ |      ​ | ​ | ​ 
 ​ | ​ 
 ​ | 2023 
 ​    | ​ |      ​ | ​ | ​ 
 ​ 
 ​ |
|:-------------------------------------------------------------------------|:--|:--|:---------------------------------------|:--|-------:|:--|:--|:--|:-----|:--|-------:|:--|:--|
| Net loss                                                                 | ​ | ​ | ​                                      | $ | -3,317 | ​